Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2013; 19(45): 8269-8281
Published online Dec 7, 2013. doi: 10.3748/wjg.v19.i45.8269
Published online Dec 7, 2013. doi: 10.3748/wjg.v19.i45.8269
Score | Patients | Controls | P value |
Grading (epithelium) | 0.001 | ||
I | 2 (20) | 8 (80) | |
II | 6 (86) | 1 (14) | |
III | 6 (100) | 0 (0) | |
Grading (lamina propria) | 0.021 | ||
I | 7 (44) | 9 (56) | |
II | 2 (100) | 0 (0) | |
III | 4 (100) | 0 (0) | |
Intensity (epithelium) | 0.480 | ||
0 | 2 (67) | 1 (33) | |
1 | 3 (43) | 4 (57) | |
2 | 9 (69) | 4 (31) | |
Intensity (lamina propria) | 0.260 | ||
0 | 4 (50) | 4 (50) | |
1 | 4 (50) | 4 (50) | |
2 | 5 (83) | 1 (17) | |
Epithelial positive cells | % (median: 25th-75th) | 0.008 | |
55 (20-70) | 5 (5-5) | ||
Lamina propria positive cells | n/10 hpf (median: 25th-75th) | 0.030 | |
5 (1-15) | 1 (0-2) |
- Citation: Ciccocioppo R, Vanoli A, Klersy C, Imbesi V, Boccaccio V, Manca R, Betti E, Cangemi GC, Strada E, Besio R, Rossi A, Falcone C, Ardizzone S, Fociani P, Danelli P, Corazza GR. Role of the advanced glycation end products receptor in Crohn’s disease inflammation. World J Gastroenterol 2013; 19(45): 8269-8281
- URL: https://www.wjgnet.com/1007-9327/full/v19/i45/8269.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i45.8269